pharma news, views and analysis

in News
Catamaran joins the CAR-NK fleet, raising $42m in first round
November 24, 2020 Share
X
Catamaran joins the CAR-NK fleet, raising $42m in first round
https://pharmaphorum.com/news/catamaran-joins-the-car-nk-fleet-raising-42m-in-first-round/
in News
FDA sets May date for verdict on ADC’s lymphoma drug Lonca
November 23, 2020 Share
X
FDA sets May date for verdict on ADC’s lymphoma drug Lonca
https://pharmaphorum.com/news/fda-sets-may-date-for-verdict-on-adcs-lymphoma-drug-lonca/

Latest News

Roche’s Herceptin/Perjeta combo product nears EU approval

The EMA’s human medicines committee has recommended approval of a fixed-dose combination of Roche’s breast cancer drugs Herceptin

Roche’s Herceptin/Perjeta combo product nears EU approval

https://pharmaphorum.com/news/roches-herceptin-perjeta-combo-product-nears-eu-approval/

NICE okays Roche liver cancer immunotherapy, Sanofi’s rare disease drug

Previously-untreated patients with hepatocellular carcinoma (HCC), a common form of liver cancer, will have an immunotherapy-based treatment option

NICE okays Roche liver cancer immunotherapy, Sanofi’s rare disease drug

https://pharmaphorum.com/news/nice-okays-roche-liver-cancer-immunotherapy-sanofis-rare-disease-drug/

Janssen combines Darzalex with COVID-19 drug in new multiple myeloma submission

Janssen has submitted a new combination regimen for its blockbuster multiple myeloma drug Darzalex for approval with the

Janssen combines Darzalex with COVID-19 drug in new multiple myeloma submission

https://pharmaphorum.com/news/janssen-combines-darzalex-with-covid-drug-in-new-multiple-myeloma-submission/

See all

Views & analysis

Being part of the conversation: Turning patient engagement to patient centricity

After three brushes with cancer, Robert Weker understands the patient journey more than many – and he is

Being part of the conversation: Turning patient engagement to patient centricity

https://pharmaphorum.com/oncology/turning-patient-engagement-to-patient-centricity/

Toxic positivity and grief: The reality of living through cancer

Cancer doesn’t end when treatment stops – it’s a lifelong journey and people need support throughout, says patient

Toxic positivity and grief: The reality of living through cancer

https://pharmaphorum.com/views-analysis-patients/toxic-positivity-and-grief-the-reality-of-living-through-cancer/

The new pharma collaborations driving transformative research in oncology

The pharmaceutical industry is one of the most scientifically innovative and competitive industries, particularly in oncology. As of

The new pharma collaborations driving transformative research in oncology

https://pharmaphorum.com/views-analysis-oncology/the-new-pharma-collaborations-driving-transformative-research-in-oncology/

See all

Debates & Insights

Cost & Management of Oncology Combination Regimens

Overview Oncology treatment increasingly involves combinations of novel oral and biologic drugs. While combo approaches aren’t new, there

Cost & Management of Oncology Combination Regimens

https://pharmaphorum.com/oncology/cost-management-of-oncology-combination-regimens/

Cancer, genomics and personalised medicine: Modelling oncology’s future

Overview The prevalence of cancer is currently predicted to be higher than ever. Current statistics show 1 in

Cancer, genomics and personalised medicine: Modelling oncology’s future

https://pharmaphorum.com/oncology/cancer-genomics-and-personalised-medicine-modelling-the-future-of-oncology/

11/06/2017

Improving Outcomes Through Industry Partnership – Learnings from the Cancer Vanguard

A unique example of partnership working across the health system, focusses on the service at large, not just the pill, and uses leading-edge data analytics to analyse, benchmark and visualise the current state of the cancer pathways within the Cancer Vanguard Trusts. Furthermore, it encompasses multiple aspects of the service provision ranging from patient outcomes and experiences, the flow of treatment and the usage of medicine in order to inform an evidence-based and patient-centric approach to service redesign and resource optimisation.

Improving Outcomes Through Industry Partnership – Learnings from the Cancer Vanguard

https://pharmaphorum.com/debates-insight-oncology/improving-outcomes-through-industry-partnership-learnings-from-the-cancer-vanguard/

See all

Partner Content

J+D Forecasting strike the balance for the liquid tumour market

Greater confidence in outputs and decision-making

J+D Forecasting strike the balance for the liquid tumour market

https://pharmaphorum.com/partner-content/jd-forecasting-strike-the-balance-for-the-liquid-tumour-market/

Q&A with SKAN AG speaker released for HPAPI 2020

HPAPI Speaker Interview

Q&A with SKAN AG speaker released for HPAPI 2020

https://pharmaphorum.com/partner-content/qa-with-skan-ag-speaker-released-forhpapi-2020/

Attendee List Released for SMi’s 9th Annual RNA Therapeutics

RNA Therapeutics

Attendee List Released for SMi’s 9th Annual RNA Therapeutics

https://pharmaphorum.com/partner-content-oncology/attendee-list-released-for-smis-9th-annual-rna-therapeutics/

See all

Search

Advanced Search

Trending